secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001006837-25-000126
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q3 rev $347M (+43% YoY); net loss narrows to $9.4M; initiates sales processes for DBM Global and Spectrum
--------------------------------------------------------------------------------

- Revenue $347.1M, up 43.3% YoY; net loss attributable to common/preferred $9.4M vs $15.3M; EPS -$0.71 vs -$1.18.
- Total Adjusted EBITDA $19.8M (+17.9% YoY). Infrastructure revenue $338.4M (+45.4%); segment Adj. EBITDA $23.5M.
- MediBeacon received NMPA approval to sell Transdermal GFR System in China; expects availability before year-end.
- Missed Sep 1, 2025 debt milestone triggered mandatory sales process for DBM Global; missed Nov 1 milestone for HC2 Broadcasting.
- Adjusted backlog for DBMG $1.6B; added $431M in new awards after Q3. Cash $35.5M at Sep 30 (vs $48.8M year-end 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683725000126/0001006837-25-000126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683725000126/vate-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001006837-25-000126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer